ABVC

ABVC BioPharma, Inc. ABVC

ABVC
ABVC BioPharma, Inc. LIMN
Liminatus Pharma, Inc. Class A Common Stock OTLC
Oncotelic Therapeutics, Inc. INNMF
Amplia Therapeutics Limited JUNS
Jupiter Neurosciences, Inc. FGEN
FibroGen, Inc. RNXT
RenovoRx, Inc. RVPH
Reviva Pharmaceuticals Holdings, Inc. ANVS
Annovis Bio, Inc. ZIVO
ZIVO Bioscience, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ABVC LIMN OTLC INNMF JUNS FGEN RNXT RVPH ANVS ZIVO
6M 236.98 % -71.06 % 74.59 % 173.62 % 191.68 % 59.88 % 40.54 % -7.69 % 27.69 % -12.00 %
YTD 380.50 % -71.06 % 164.71 % 213.66 % -85.22 % -16.25 % -20.22 % -69.01 % -67.51 % -38.52 %
1Y 516.00 % -71.06 % 200.00 % 21.32 % -71.77 % 29.14 % 8.50 % -49.37 % -77.90 % -34.62 %
3Y -62.89 % -71.06 % 56.88 % 51.29 % -71.77 % -97.13 % -34.24 % -83.99 % -86.86 % -30.16 %
5Y -92.58 % -71.06 % -52.63 % -33.63 % -71.77 % -99.09 % -85.06 % -94.22 % -66.73 % 1 366.67 %
10Y -99.79 % -71.06 % -89.89 % -33.63 % -71.77 % -97.84 % -85.06 % -93.59 % -82.69 % 2 650.00 %
From the beginning -100.00 % -71.06 % -99.99 % -33.63 % -71.77 % -97.99 % -85.06 % -93.59 % -82.69 % -31.25 %

Dividend